Fulltext

Osimertinib as first-line treatment of EGFR mutant advanced non-small-cell lung cancer

Liam CK 1

Affiliations 

  • 1 Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
Transl Lung Cancer Res, 2017 Dec;6(Suppl 1):S62-S66.
PMID: 29299414 DOI: 10.21037/tlcr.2017.10.10

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications